TABLE 1

Baseline characteristics of 115 patients with an acute PCI-treated STEMI

Patients
Age (years)59 (52, 68)
Male, n (%)97 (84)
Previous disorder:
 MI, n (%)5 (4.3)
 Angina pectoris, n (%)3 (2.6)
 Hypertension (treated), n (%)23 (20.0)
 Hyperlipidemia (treated), n (%)9 (7.8)
Status at baseline:
 Current smoker, n (%)49 (42.6)
 cTnTmax (μg/L)5.0 (2.5, 9.7)
 BMI (kg/m2)26 (24.3, 28.6)
 Waist circumference (cm)99 (94, 106)
 Stent in culprit lesion, n (%)109 (94.8)
 Gp IIb/IIIa inhibitor-treated, n (%)39 (33.9)
 Single-coronary vessel disease, n (%)73 (63.5)
 Double-coronary vessel disease, n (%)34 (29.6)
 Triple-coronary vessel disease, n (%)8 (7.0)
 Time from symptoms to balloon (min)239 (155, 370)
Medication at admission:
 Aspirin10 (8.7)
 β-Blockers11 (9.6)
 Lipid-lowering agents7 (6.1)
 ACE inhibitors3 (2.6)
 Angiotensin II receptor blockers11 (9.6)
  • Data are presented as median values (25th, 75th percentiles) or proportions (%). cTnTmax, cTnT maximum; Gp, glycoprotein.